SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008527
Filing Date
2019-09-09
Accepted
2019-09-09 08:31:13
Documents
57
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20190731x10q.htm 10-Q 1759603
2 EX-10.1 bpmx-20190731ex1013705bc.htm EX-10.1 74233
3 EX-31.1 bpmx-20190731ex311e7da57.htm EX-31.1 19592
4 EX-31.2 bpmx-20190731ex312bd9467.htm EX-31.2 19686
5 EX-32.1 bpmx-20190731ex321af3cb0.htm EX-32.1 10168
6 EX-32.2 bpmx-20190731ex322ae7f84.htm EX-32.2 10008
  Complete submission text file 0001558370-19-008527.txt   5706024

Data Files

Seq Description Document Type Size
7 EX-101.INS bpmx-20190731.xml EX-101.INS 1133057
8 EX-101.SCH bpmx-20190731.xsd EX-101.SCH 34174
9 EX-101.CAL bpmx-20190731_cal.xml EX-101.CAL 36496
10 EX-101.DEF bpmx-20190731_def.xml EX-101.DEF 131824
11 EX-101.LAB bpmx-20190731_lab.xml EX-101.LAB 303337
12 EX-101.PRE bpmx-20190731_pre.xml EX-101.PRE 257086
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 191081199
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1